Neurology
Webinar 3 – Epilepsy: Historical Perspectives, Current Practice an Future Directions
This is a series of three 60-minute interactive MOC Section 1 accredited virtual live webinars for Canadian neurologists, epileptologists and other healthcare providers. The goal is to provide education on the evolution of epilepsy care, with a particular focus on the substantial burden of drug-resistant epilepsy (DRE). This webinar series is designed to provide an overview of epilepsy through the lens of time, including historical perspectives, current practice, and the future of epilepsy care. A review of a case example of an individual with DRE will supplement learning and provide practical application of how epilepsy care has progressed.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2025-03-06
Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial number of patients facing drug-resistant epilepsy (DRE). The historical journey from superstition to scientific understanding has greatly influenced the contemporary landscape of epilepsy research and treatment. Dating back to ancient times, epilepsy was often shrouded in misconceptions and attributed to supernatural causes. It was not until the late 19th and early 20th centuries that scientific advancements, such as the discovery of the electrical nature of brain activity, laid the foundation for a more accurate understanding of epilepsy. This newfound knowledge spurred the development of early treatments, including the introduction of antiseizure medications in the mid-20th century. While traditional antiseizure medications (ASMs) have been the cornerstone of epilepsy management for decades, a significant proportion of patients continue to experience seizures despite treatment. Ongoing research and technological advancements are paving the way for more targeted and personalized treatment approaches, offering hope for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Labs Inc.
Faculty
Moderator:
- Esther Bui, MD, FRCPC
Panelist:
- Danielle Andrade, MD, MSc, FRCPC
Learning objectives
After completion of the webinar participants will be better able to:
- Understand the genetics of epilepsy, including single-gene mutations and polygenic risk scores, and their effects on treatment
- Evaluate precision therapies in epilepsy management and their role in personalized care
- Investigate the role of AI, machine learning, and big data in seizure detection and advancing epilepsy care
- Discuss future innovations in epilepsy surgery and wearable technology that improve precision and treatment outcomes
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the ____________. You may claim a maximum of 1.0 hour (credits are automatically calculated).
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Specialist
Profession
1
# of credits
Learning Objectives
After completion of the webinar participants will be better able to:
- Understand the genetics of epilepsy, including single-gene mutations and polygenic risk scores, and their effects on treatment
- Evaluate precision therapies in epilepsy management and their role in personalized care
- Investigate the role of AI, machine learning, and big data in seizure detection and advancing epilepsy care
- Discuss future innovations in epilepsy surgery and wearable technology that improve precision and treatment outcomes
MOC - Section 1
ACCREDITATION
Neurology
Learning Category
Epilepsy
Topic
0
Price
2025-03-06
Expiry Date
CAN-eng
Region/Language
Course Description
Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial number of patients facing drug-resistant epilepsy (DRE). The historical journey from superstition to scientific understanding has greatly influenced the contemporary landscape of epilepsy research and treatment. Dating back to ancient times, epilepsy was often shrouded in misconceptions and attributed to supernatural causes. It was not until the late 19th and early 20th centuries that scientific advancements, such as the discovery of the electrical nature of brain activity, laid the foundation for a more accurate understanding of epilepsy. This newfound knowledge spurred the development of early treatments, including the introduction of antiseizure medications in the mid-20th century. While traditional antiseizure medications (ASMs) have been the cornerstone of epilepsy management for decades, a significant proportion of patients continue to experience seizures despite treatment. Ongoing research and technological advancements are paving the way for more targeted and personalized treatment approaches, offering hope for individuals with DRE.
This program has received an unrestricted educational grant or in-kind support from Paladin Labs Inc.
Faculty
Moderator:
- Esther Bui, MD, FRCPC
Panelist:
- Danielle Andrade, MD, MSc, FRCPC
Accreditation
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the ____________. You may claim a maximum of 1.0 hour (credits are automatically calculated).
1 hr
Duration
0
Price
1
# of credits
